ArticleJournal of molecular histology2026
Glomerular epithelial protein-1 promotes reparative dentin formation in vivo.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Glomerular epithelial protein-1 (Glepp1/PTPRO), a member of the R3 subtype family of receptor-type protein tyrosine phosphatases that, regulates cellular processes, like proliferation, differentiation, and apoptosis, involved in odontogenesis, with its overexpression causing thicker dentin. However, its in vivo impact during reparative dentin formation remains unexplored. This study evaluated an alternative therapeutic approach of enhancing natural dentin repair by overexpressing Glepp1 in an animal model. A pulp access cavity was prepared on the upper right first molar of eight-week-old male mice, followed by local delivery of Glepp1 adeno-associated virus (AAV) or phosphate-buffered saline (PBS). Hematoxylin and eosin (H&E) staining and immunohistochemistry were used to assess histological and cellular physiological changes after three and five days of treatment. Micro-CT and H&E analyses 42 days after AAV-mediated delivery revealed significantly enhanced dentin bridge formation and increased mineralized tissue deposition in the Glepp1 AAV-delivered group. Glepp1 AAV-delivered samples showed increased immunolocalization of reparative dentin-related markers, including Nestin, runt-related transcription factor 2 (RUNX2), osteocalcin (OCN), and osteopontin (OPN) at days 3 and 5, suggesting enhanced mineralization and extracellular matrix formation. Furthermore, decreased tumor necrosis factor α (TNFα) and increased transforming growth factor β - 1 (TGF-β1) localization with enhanced cluster of differentiation 31 (CD31) immunostaining indicated inflammatory response modulation and improved vascularization. These findings highlight local Glepp1 overexpression using the AAV system as a viable strategy for dentin-pulp regeneration via modulation of cellular and molecular mechanisms.
Indexed as
Identifiers
42821166What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.